title: Survival prediction based on inherited gene variation analysis.
abstract: There is a significant variation of outcome among ovarian cases. Clinical features such as age, stage, comorbidities, or degree of debulking are known prognostic factors for the disease. However, additional variation remains unexplained, some of which may be due to inherited factors. Here, we describe identification of survival-associated inherited variants in ovarian cancer that can enhance our current prognostic capabilities.
authors.affiliation: Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN, USA.
authors.forename: Mine S
authors.initials: MS
authors.lastname: Cicek
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Maurer
authors.forename: Ellen L
authors.initials: EL
authors.lastname: Goode
mesh_terms: D005260:Female; D014644:Genetic Variation; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000473:pathology; D020641:Polymorphism, Single Nucleotide / Q000235:genetics; D011379:Prognosis; D016019:Survival Analysis
references.citation: Cancer Sci. 2007 Mar;98(3):268-74
references.pmid: 17270016
references.citation: Nat Rev Cancer. 2009 Mar;9(3):167-81
references.pmid: 19238149
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2536-43
references.pmid: 16284375
references.citation: Nature. 2004 May 27;429(6990):446-52
references.pmid: 15164069
references.citation: Cancer Res. 1993 Feb 1;53(3):641-51
references.pmid: 7678777
references.citation: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references.pmid: 22237781
references.citation: Eur J Hum Genet. 2011 Aug;19(8):837-43
references.pmid: 21487444
references.citation: Gynecol Oncol. 2002 Mar;84(3):399-403
references.pmid: 11855877
references.citation: Curr Med Chem. 2009;16(3):287-300
references.pmid: 19149578
references.citation: Open Clin Cancer J. 2008 Feb 06;2:7-12
references.pmid: 18665245
references.citation: Nat Genet. 2005 Nov;37(11):1217-23
references.pmid: 16244653
references.citation: Bioinformatics. 2005 Jan 15;21(2):263-5
references.pmid: 15297300
references.citation: Nature. 2007 Oct 18;449(7164):851-61
references.pmid: 17943122
references.citation: J Clin Oncol. 2007 Feb 10;25(5):517-25
references.pmid: 17290060
references.citation: Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1733-45
references.pmid: 17009964
references.citation: Oncogene. 2005 Jul 28;24(32):5089-100
references.pmid: 15870691
references.citation: Adv Exp Med Biol. 2008;622:197-208
references.pmid: 18546629
references.citation: Mayo Clin Proc. 2007 Jun;82(6):751-70
references.pmid: 17550756
references.citation: JAMA. 2012 Jan 25;307(4):382-90
references.pmid: 22274685
references.citation: Dis Markers. 2008;25(4-5):219-32
references.pmid: 19126966
references.citation: Clin Cancer Res. 2003 Jan;9(1):44-51
references.pmid: 12538450
references.citation: Science. 2005 Feb 18;307(5712):1072-9
references.pmid: 15718463
references.citation: Blood. 2007 Jun 15;109(12):5439-46
references.pmid: 17327408
references.citation: Genet Epidemiol. 2007 Jul;31(5):383-95
references.pmid: 17410554
references.citation: Breast Cancer Res Treat. 2007 Apr;102(2):237-47
references.pmid: 17004113
references.citation: Gynecol Oncol. 1992 Nov;47(2):159-66
references.pmid: 1468693
references.citation: Leukemia. 2009 Mar;23(3):596-602
references.pmid: 18830263
references.citation: Front Biosci. 2005 May 01;10:1881-96
references.pmid: 15769673
references.citation: Biostatistics. 2006 Apr;7(2):167-81
references.pmid: 16332926
references.citation: N Engl J Med. 2004 Dec 9;351(24):2519-29
references.pmid: 15590954
references.citation: Gynecol Oncol. 2008 Jul;110(1):49-55
references.pmid: 18423560
references.citation: Crit Rev Clin Lab Sci. 2004;41(2):189-231
references.pmid: 15270554
references.citation: Blood. 2008 Oct 1;112(7):2694-702
references.pmid: 18633131
references.citation: Am J Obstet Gynecol. 2003 Oct;189(4):1120-7
references.pmid: 14586365